ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel

被引：0
|
作者：
Lifeng Wang
Jia Wei
Xiaoping Qian
Haitao Yin
Yang Zhao
Lixia Yu
Tingting Wang
Baorui Liu
机构：
[1] Drum Tower Hospital Affiliated to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University,Department of Oncology
[2] Nanjing Medical University,Department of Epidemiology and Biostatistics, Epidemiology and Biostatistics Graduate Program, Data Analysis Center, School of Public Health
来源：
BMC Cancer | / 8卷
关键词：
Docetaxel; Gastric Cancer Patient; Nucleotide Excision Repair; Malignant Pleural Effusion; BRCA1 Expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Evaluation of ERCC1 Expression for Cisplatin Sensitivity in Human Hepatocellular Carcinoma
    Shigeru Ueda
    Ken Shirabe
    Kazutoyo Morita
    Kenji Umeda
    Hiroto Kayashima
    Hideaki Uchiyama
    Yuji Soejima
    Akinobu Taketomi
    Yoshihiko Maehara
    Annals of Surgical Oncology, 2011, 18 : 1204 - 1211
  • [42] Evaluation of ERCC1 Expression for Cisplatin Sensitivity in Human Hepatocellular Carcinoma
    Ueda, Shigeru
    Shirabe, Ken
    Morita, Kazutoyo
    Umeda, Kenji
    Kayashima, Hiroto
    Uchiyama, Hideaki
    Soejima, Yuji
    Taketomi, Akinobu
    Maehara, Yoshihiko
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (04) : 1204 - 1211
  • [43] Quantifying BRCA1 and BRCA2 mRNA Isoform Expression Levels in Single Cells
    Lattimore, Vanessa L.
    Pearson, John F.
    Morley-Bunker, Arthur E.
    Spurdle, Amanda B.
    Robinson, Bridget A.
    Currie, Margaret J.
    Walker, Logan C.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03):
  • [44] RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced NSCLC patients treated with cisplatin -based chemotherapy
    Li Zhanxia
    Zhou Songwen
    Zhang Ling
    Ren Shengxiang
    Zhou Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S915 - S916
  • [45] PROGNOSTIC VALUE OF CD133 EXPRESSION AND IT'S COMBINATION WITH EXPRESSIONS OF ERCC1, RRM1 AND BRCA1 IN LUNG CANCER
    Su, Chunxia
    Xu, Guotong
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1014 - S1014
  • [46] PROGNOSTIC VALUE OF CD133 EXPRESSION AND IT'S COMBINATION WITH EXPRESSIONS OF ERCC1, RRM1 AND BRCA1 IN LUNG CANCER
    Su, C.
    Xu, G.
    Zhou, C.
    RESPIROLOGY, 2011, 16 : 185 - 185
  • [47] mRNA Expression and Clinical Significance of ERCC1, BRCA1, RRM1, TYMS and TUBB3 in Postoperative Patients with Non-Small Cell Lung Cancer
    Han, Yi
    Wang, Xiao-Bin
    Xiao, Ning
    Liu, Zhi-Dong
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (05) : 2987 - 2990
  • [48] Expression of BRCA1 and ERCC1 as predictive clinical outcome after radiochemotherapy in patients with locoregionally moderate-advanced nasopharyngeal carcinoma
    Xu, Shan
    Yu, Yanxin
    Rong, Jinfeng
    Hu, Defeng
    Zhang, LiJun
    Fu, Shaozhi
    Yang, Hongru
    Fan, Juan
    Yang, Linglin
    Wu, Jingbo
    ONCOTARGET, 2017, 8 (19) : 31355 - 31367
  • [49] DNA Repair Genes ERCC1 and BRCA1 Expression in Non-Small Cell Lung Cancer Chemotherapy Drug Resistance
    Wang, Shuai
    Liu, Feng
    Zhu, Jingyan
    Chen, Peng
    Liu, Hongxing
    Liu, Qi
    Han, Junqing
    MEDICAL SCIENCE MONITOR, 2016, 22 : 1999 - 2005
  • [50] ERCC5/XPG, ERCC1, and BRCA1 Gene Status and Clinical Benefit of Trabectedin in Patients With Soft Tissue Sarcoma
    Italiano, Antoine
    Laurand, Armelle
    Laroche, Audrey
    Casali, Paolo
    Sanfilippo, Roberta
    Le Cesne, Axel
    Judson, Ian
    Blay, Jean-Yves
    Ray-Coquard, Isabelle
    Bui, Binh
    Coindre, Jean-Michel
    Nieto, Antonio
    Tercero, Juan-Carlos
    Jimeno, Jose
    Robert, Jacques
    Pourquier, Philippe
    CANCER, 2011, 117 (15) : 3445 - 3456
12345